A 2-year comparative open label randomized study of efficacy and safety of etanercept and infliximab in patients with ankylosing spondylitis.

Giardina AR, Ferrante A, Ciccia F, Impastato R, Miceli MC, Principato A, Triolo G

Open source

DOI
10.1007/s00296-009-1157-3
Published
2010 Sep
Container
Rheumatology international
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00296-009-1157-3,
  title = {A 2-year comparative open label randomized study of efficacy and safety of etanercept and infliximab in patients with ankylosing spondylitis.},
  author = {Giardina AR and Ferrante A and Ciccia F and Impastato R and Miceli MC and Principato A and Triolo G},
  year = {2010},
  journal = {Rheumatology international},
  doi = {10.1007/s00296-009-1157-3},
  url = {https://doi.org/10.1007/s00296-009-1157-3}
}

RIS

TY  - JOUR
TI  - A 2-year comparative open label randomized study of efficacy and safety of etanercept and infliximab in patients with ankylosing spondylitis.
AU  - Giardina AR
AU  - Ferrante A
AU  - Ciccia F
AU  - Impastato R
AU  - Miceli MC
AU  - Principato A
AU  - Triolo G
PY  - 2010
JO  - Rheumatology international
DO  - 10.1007/s00296-009-1157-3
UR  - https://doi.org/10.1007/s00296-009-1157-3
ER  - 

APA

AR, G., A, F., F, C., R, I., MC, M., A, P., & G, T. (2010). A 2-year comparative open label randomized study of efficacy and safety of etanercept and infliximab in patients with ankylosing spondylitis.. Rheumatology international. https://doi.org/10.1007/s00296-009-1157-3

Source records